Cigna sinks on investor worries about Trump drug rebate rule change

Cigna CEO David Cordani doesn't see the Trump administration's new proposal to cut Medicare pharmacy benefit rebates as a threat to its growth, as it embarks on integrating its newly acquired PBM firm Express Scripts.